132 related articles for article (PubMed ID: 8948511)
21. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.
Szabó C; Mitchell JA; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Mar; 108(3):786-92. PubMed ID: 7682137
[TBL] [Abstract][Full Text] [Related]
22. Inability of rat alveolar macrophages to recycle L-citrulline to L-arginine despite induction of argininosuccinate synthetase mRNA and protein, and inhibition of nitric oxide synthesis by exogenous L-citrulline.
Hammermann R; Bliesener N; Mössner J; Klasen S; Wiesinger H; Wessler I; Racké K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):601-7. PubMed ID: 9879717
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha modulates the expression of its p60 receptor and several cytokines in rat tracheal epithelial cells.
Bader T; Nettesheim P
J Immunol; 1996 Oct; 157(7):3089-96. PubMed ID: 8816419
[TBL] [Abstract][Full Text] [Related]
24. Induction of adhesion/differentiation of human neuroblastoma cells by tumour necrosis factor-alpha requires the expression of an inducible nitric oxide synthase.
Obregón E; Punzón MC; González-Nicolás J; Fernandez-Cruz E; Fresno M; Muñoz-Fernández MA
Eur J Neurosci; 1997 Jun; 9(6):1184-93. PubMed ID: 9215702
[TBL] [Abstract][Full Text] [Related]
25. Ketamine inhibits nitric oxide synthase in lipopolysaccharide-treated rat alveolar macrophages.
Li CY; Chou TC; Wong CS; Ho ST; Wu CC; Yen MH; Ding YA
Can J Anaesth; 1997 Sep; 44(9):989-95. PubMed ID: 9305563
[TBL] [Abstract][Full Text] [Related]
26. Increased nitric oxide synthase activity as a cause of mitochondrial dysfunction in rat hepatocytes: roles for tumor necrosis factor alpha.
Kurose I; Miura S; Higuchi H; Watanabe N; Kamegaya Y; Takaishi M; Tomita K; Fukumura D; Kato S; Ishii H
Hepatology; 1996 Nov; 24(5):1185-92. PubMed ID: 8903396
[TBL] [Abstract][Full Text] [Related]
27. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
Thiemermann C; Ruetten H; Wu CC; Vane JR
Br J Pharmacol; 1995 Dec; 116(7):2845-51. PubMed ID: 8680715
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of nitric oxide synthase abrogates lipopolysaccharides-induced up-regulation of L-arginine uptake in rat alveolar macrophages.
Hammermann R; Stichnote C; Closs EI; Nawrath H; Racké K
Br J Pharmacol; 2001 Jun; 133(3):379-86. PubMed ID: 11375254
[TBL] [Abstract][Full Text] [Related]
29. Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.
Mitchell JA; Kohlhaas KL; Sorrentino R; Warner TD; Murad F; Vane JR
Br J Pharmacol; 1993 May; 109(1):265-70. PubMed ID: 7684306
[TBL] [Abstract][Full Text] [Related]
30. Thaliporphine selectively inhibits expression of the inducible, but not the constitutive, nitric oxide synthase.
Yu SM
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):289-94. PubMed ID: 7524482
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide synthase mRNA in endothelial cells: synergistic induction by interferon-gamma, tumor necrosis factor-alpha and lipopolysaccharide and inhibition by dexamethasone.
Marumo T; Nakaki T; Adachi H; Esumi H; Suzuki H; Saruta T; Kato R
Jpn J Pharmacol; 1993 Nov; 63(3):327-34. PubMed ID: 7509009
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties.
Cirino G; Wheeler-Jones CP; Wallace JL; Del Soldato P; Baydoun AR
Br J Pharmacol; 1996 Apr; 117(7):1421-6. PubMed ID: 8730734
[TBL] [Abstract][Full Text] [Related]
33. Polyamines, NO and cGMP mediate stimulation of DNA synthesis by tumor necrosis factor and lipopolysaccharide in chick embryo cardiomyocytes.
Tantini B; Flamigni F; Pignatti C; Stefanelli C; Fattori M; Facchini A; Giordano E; Clô C; Caldarera CM
Cardiovasc Res; 2001 Feb; 49(2):408-16. PubMed ID: 11164851
[TBL] [Abstract][Full Text] [Related]
34. HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro.
Abou-Mohamed G; Papapetropoulos A; Ulrich D; Catravas JD; Tuttle RR; Caldwell RW
J Pharmacol Exp Ther; 1995 Nov; 275(2):584-91. PubMed ID: 7473142
[TBL] [Abstract][Full Text] [Related]
35. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide.
Heneka MT; Löschmann PA; Gleichmann M; Weller M; Schulz JB; Wüllner U; Klockgether T
J Neurochem; 1998 Jul; 71(1):88-94. PubMed ID: 9648854
[TBL] [Abstract][Full Text] [Related]
36. Expression of citrulline-nitric oxide cycle in lipopolysaccharide and cytokine-stimulated rat astroglioma C6 cells.
Zhang WY; Takiguchi M; Koshiyama Y; Gotoh T; Nagasaki A; Iwase K; Yamamoto K; Takeshima H; Negi A; Mori M
Brain Res; 1999 Dec; 849(1-2):78-84. PubMed ID: 10592289
[TBL] [Abstract][Full Text] [Related]
37. Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture.
Reykdal S; Abboud C; Liesveld J
Exp Hematol; 1999 Mar; 27(3):441-50. PubMed ID: 10089906
[TBL] [Abstract][Full Text] [Related]
38. Synergistic regulation of NOS II expression by IL-1 beta and TNF-alpha in cultured rat colonic smooth muscle cells.
Kuemmerle JF
Am J Physiol; 1998 Jan; 274(1):G178-85. PubMed ID: 9458787
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of L-arginine transport, in activated murine macrophage J774 cells.
Baydoun AR; Bogle RG; Pearson JD; Mann GE
Br J Pharmacol; 1993 Dec; 110(4):1401-6. PubMed ID: 7508326
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
Fedan JS; Warner TE; Yuan LX; Robinson Va; Frazer DG
J Pharmacol Exp Ther; 1995 Mar; 272(3):1141-50. PubMed ID: 7534351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
